Family Legacy Inc’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.17M | Sell |
7,423
-16
| -0.2% | -$5.26K | 0.65% | 59 |
|
|
2025
Q4 | $2.61M | Buy |
7,439
+55
| +0.7% | +$18.6K | 0.78% | 50 |
|
|
2025
Q3 | $2.39M | Buy |
7,384
+225
| +3% | +$70K | 0.73% | 52 |
|
|
2025
Q2 | $2.78M | Buy |
7,159
+202
| +3% | +$81.2K | 0.91% | 44 |
|
|
2025
Q1 | $3.03M | Buy |
6,957
+126
| +2% | +$50.6K | 1.04% | 41 |
|
|
2024
Q4 | $2.62M | Buy |
6,831
+232
| +4% | +$97.1K | 0.89% | 44 |
|
|
2024
Q3 | $3.43M | Buy |
6,599
+127
| +2% | +$67.8K | 1.14% | 35 |
|
|
2024
Q2 | $3.51M | Sell |
6,472
-106
| -2% | -$56K | 1.26% | 34 |
|
|
2024
Q1 | $3.41M | Buy |
6,578
+10
| +0.2% | +$4.97K | 1.23% | 34 |
|
|
2023
Q4 | $3.1M | Buy |
6,568
+1
| +0% | +$462 | 1.18% | 36 |
|
|
2023
Q3 | $2.86M | Buy |
6,567
+57
| +0.9% | +$25.9K | 1.19% | 34 |
|
|
2023
Q2 | $2.89M | Sell |
6,510
-16
| -0.2% | -$7.38K | 1.16% | 36 |
|
|
2023
Q1 | $3M | Buy |
6,526
+204
| +3% | +$97.1K | 1.28% | 34 |
|
|
2022
Q4 | $3.13M | Buy |
6,322
+301
| +5% | +$153K | 1.37% | 33 |
|
|
2022
Q3 | $2.73M | Buy |
6,021
+118
| +2% | +$56.5K | 1.37% | 30 |
|
|
2022
Q2 | $2.82M | Sell |
5,903
-33
| -0.6% | -$16.3K | 1.34% | 29 |
|
|
2022
Q1 | $2.92M | Buy |
5,936
+8
| +0.1% | +$3.66K | 1.22% | 33 |
|
|
2021
Q4 | $2.69M | Buy |
5,928
+144
| +2% | +$60.6K | 1.1% | 37 |
|
|
2021
Q3 | $2.23M | Buy |
5,784
+26
| +0.5% | +$9.88K | 1.01% | 43 |
|
|
2021
Q2 | $2.21M | Buy |
5,758
+117
| +2% | +$44.7K | 0.99% | 46 |
|
|
2021
Q1 | $2.02M | Buy |
5,641
+146
| +3% | +$47K | 0.97% | 47 |
|
|
2020
Q4 | $1.76M | Buy |
5,495
+166
| +3% | +$50.9K | 0.91% | 46 |
|
|
2020
Q3 | $1.43M | Buy |
5,329
+155
| +3% | +$41.7K | 0.81% | 50 |
|
|
2020
Q2 | $1.36M | Sell |
5,174
-30
| -0.6% | -$8K | 0.82% | 49 |
|
|
2020
Q1 | $1.18M | Buy |
5,204
+75
| +1% | +$20.4K | 0.85% | 45 |
|
|
2019
Q4 | $1.58M | Buy |
5,129
+68
| +1% | +$18.7K | 0.9% | 46 |
|
|
2019
Q3 | $1.42M | Buy |
5,061
+1,672
| +49% | +$458K | 0.88% | 48 |
|
|
2019
Q2 | $956K | Buy |
3,389
+93
| +3% | +$25.4K | 0.75% | 54 |
|
|
2019
Q1 | $954K | Buy |
3,296
+60
| +2% | +$17.4K | 0.77% | 49 |
|
|
2018
Q4 | $850K | Buy |
3,236
+371
| +13% | +$102K | 0.76% | 50 |
|
|
2018
Q3 | $785K | Buy |
2,865
+143
| +5% | +$37.1K | 0.64% | 59 |
|
|
2018
Q2 | $648K | Buy |
2,722
+263
| +11% | +$60.9K | 0.56% | 58 |
|
|
2018
Q1 | $540K | Buy |
2,459
+103
| +4% | +$24.2K | 0.5% | 61 |
|
|
2017
Q4 | $530K | Buy |
+2,356
| New | +$502K | 0.48% | 63 |
|
Other funds holding ELV
VCM
VPM
Family Legacy Inc's ELV Position: Q1 2026 in Review
Family Legacy Inc reduced its Elevance Health (ELV) stake by 0.22% in Q1 2026, selling an estimated $5.26K and leaving 7,423 shares worth $2.17M. The position accounts for 0.65% of the portfolio, ranked #59.
Family Legacy Inc first reported a position in ELV in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.51M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Family Legacy Inc held 7,423 shares of Elevance Health worth $2.17M as of Q1 2026.
- Family Legacy Inc sold 16 Elevance Health shares in Q1 2026, an estimated $5.26K.
- Elevance Health made up 0.65% of Family Legacy Inc's portfolio in Q1 2026, its #59 holding.
- Family Legacy Inc first reported a position in Elevance Health in Q4 2017 and has held it in 34 quarters since.
- Family Legacy Inc's Elevance Health position peaked at $3.51M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Family Legacy Inc's 13F filing for Q1 2026, filed 12 May 2026.